COMMUNIQUÉS West-GlobeNewswire

Bonito Biosciences and DaltonTx Announce AI-Driven Collaboration to Advance Precision Delivery for Oligotherapeutics
27/05/2026
Collaboration combines Bonito’s proprietary functional delivery data engine and ligand discovery platform with Dalton Tx ’s adaptive AI technology to accelerate precision oligotherapeutic delivery, beginning in the CNS [...]
Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships
27/05/2026
The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services French Ministry approval recognizes Intravacc as a private research [...]
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
27/05/2026
Press release – No. 10 / 2026 Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as ePoster Theater [...]
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
27/05/2026
Long-term follow up data from the Phase 1 study of pevifoscorvir sodium continues to suggest a reduction in the cccDNA reservoir Data on the preclinical characteristics of the Aligos/Amoytop ASO program to be presented [...]
New study reveals promising new way to find serious liver disease earlier
27/05/2026
SOMERSET, United Kingdom and BARCELONA, Spain, May 27, 2026 (GLOBE NEWSWIRE) -- Predictive Health Intelligence today announced a promising new way to identify people with serious liver disease earlier, using existing [...]
Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management
27/05/2026
Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO—a certified algorithm developed by the [...]
Remarcate Limited Liability Company Expands Into U.S. Market to Support Hispanic Healthcare Providers With AI-Driven Patient Acquisition Systems
27/05/2026
WESLEY CHAPEL, FL, May 27, 2026 (GLOBE NEWSWIRE) -- Remarcate Limited Liability Company, a Florida-based healthcare marketing and patient acquisition company, announced the expansion of its operations into the United [...]
argenx to Present at Upcoming Investor Conferences
27/05/2026
May 27, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that [...]
Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC
27/05/2026
SHANGHAI, May 26, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Vireo Growth Inc. Exercises Option to Purchase New York Facility from Innovative Industrial Properties
27/05/2026
MINNEAPOLIS, May 26, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that its subsidiary, 256 County Route 117 Perth LLC (the “Buyer”), completed the [...]
Inventiva publie ses informations financières du premier trimestre 2026¹
26/05/2026
Trésorerie et équivalents de trésorerie de 75 millions d'euros, et 121,5millions d'euros de dépôts à court terme 2025 2 Daix (France), New York City (New York, United States), le 26 mai 2026 – Inventiva (Euronext Paris [...]
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
26/05/2026
Drs. Sang-Won Lee and Jaewoo Kang to share early insights from Seer's 20,000-sample collaboration with Korea University in breakfast symposium on AI-driven multi-cancer screening REDWOOD CITY, Calif., May 26, 2026 ( [...]
Inventiva Reports 2026 First Quarter Financial Information¹
26/05/2026
Cash and cash equivalents at €75.0 million, and €121.5 million in short-term deposits 2 Daix (France), New York City (New York, United States), May 26, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or [...]
Dianthus Therapeutics to Participate in Two Investor Conferences
26/05/2026
NEW YORK and WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Spyre Therapeutics to Participate in Upcoming June Investor Conferences
26/05/2026
WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of [...]
Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference
26/05/2026
WESTLAKE VILLAGE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
OrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
26/05/2026
WARSAW, Ind., May 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
26/05/2026
SAN FRANCISCO, May 26, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
26/05/2026
New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence SALT LAKE CITY, May 26, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic [...]

Pages